Related Experiment Video
Updated: Apr 30, 2026
08:55
Expression, Solubilization, and Purification of Eukaryotic Borate Transporters
Published on: March 7, 2019
12.1K
[Recent progress and prospects for research on urate efflux transporter ABCG2]
Summary
Genetic variants in the ABCG2 transporter cause dysfunction, significantly increasing gout and hyperuricemia risk. This dysfunction, particularly severe forms, is linked to early-onset gout and often misdiagnosed as overproduction hyperuricemia.
Area of Science:
- Genetics and Molecular Biology
- Metabolic Disorders
- Nephrology
Background:
- ATP-binding cassette super-family G member 2 (ABCG2) functions as a critical high-capacity urate exporter.
- Common genetic variants, Q126X (nonfunctional) and Q141K (half-functional), impact ABCG2 transporter activity.
- Existing hyperuricemia classifications overlook extra-renal urate excretion pathways.
Purpose of the Study:
- To investigate the role of ABCG2 dysfunction in gout and hyperuricemia.
- To clarify the contribution of ABCG2 variants to urate metabolism.
- To re-evaluate the classification of hyperuricemia, considering extra-renal pathways.
Main Methods:
- Analysis of common ABCG2 variants (Q126X and Q141K) and their haplotypes.
- Estimation of ABCG2 dysfunction based on variant combinations.
- Correlation of ABCG2 dysfunction with gout and hyperuricemia risk, including early-onset cases.
Main Results:
- ABCG2 dysfunction, particularly due to Q126X and Q141K haplotypes, significantly elevates gout and hyperuricemia risk.
- ABCG2 dysfunction is identified in approximately 80% of gout patients.
- Severe ABCG2 dysfunction is strongly associated with an increased risk of early-onset gout.
Conclusions:
- A significant portion of hyperuricemia, previously termed 'overproduction type', is attributable to extra-renal urate underexcretion caused by ABCG2 dysfunction.
- ABCG2 dysfunction is a primary etiological factor in the majority of gout cases.
- Targeting ABCG2 offers a novel therapeutic and preventative strategy for gout and hyperuricemia.
Related Concept Videos
01:31ABC Transporters: Exporter
5.7K
ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
5.7K
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
189
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
189
01:27ABC Transporters: Importer
2.7K
ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
2.7K
01:06Carrier-Mediated Transport
1.6K
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.6K
01:44The Significance of Membrane Transport
24.3K
The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
24.3K
01:27Glucose Transporters
15.2K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
15.2K